Literature DB >> 15382035

Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients.

Charlotte F J M Peeters1, Johan R Westphal, Robert M W de Waal, Dirk J Ruiter, Theo Wobbes, Theo J M Ruers.   

Abstract

In animal models, explosive growth of metastases after removal of the primary tumor has been attributed to abolishment of angiogenesis inhibition. We investigated the influence of (removal of) the primary tumor on vascularization of liver metastases in human colorectal cancer patients. We analyzed vascular density in synchronous liver metastases from patients with the primary tumor in situ, in synchronous metastases from patients with the primary tumor resected and in metachronous metastases. In a limited number of cases, biopsies from metastases from the same patient before and within 3 months after resection were analyzed. In addition, vascular density in metastases was compared to the vascular density in the corresponding primary tumor. Peritumoral and intratumoral vascular density were determined by staining for endothelial antigens CD31 and CD34, respectively. Both peritumoral and intratumoral vascular density were elevated in synchronous metastases from patients with the primary tumor removed compared to synchronous metastases from patients with the primary tumor in situ. Comparable results were observed in patients with metachronous metastases. An increase in vascular density after resection of the colorectal malignancy was also observed in biopsies taken from the same patient before and after tumor resection. Remarkably, vascular density in the liver metastases was always lower than that in the corresponding primary tumor. Our data show for the first time in humans that the presence of a primary tumor is correlated with decreased vascularization of its distant metastases. Resection of the primary tumor results in an increased vascularization of metastatic lesions. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15382035     DOI: 10.1002/ijc.20374

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  The influence of local therapy on the survival of patients with metastatic rectal cancer: a population-based, propensity-matched study.

Authors:  Chi-Hao Zhang; Yuan-Bo Pan; Qing-Wei Zhang; Ou-Min Shi; Lei Zheng; Liang Gui; Meng Luo
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-22       Impact factor: 4.553

2.  Modeling the connection between primary and metastatic tumors.

Authors:  David Diego; Gabriel F Calvo; Víctor M Pérez-García
Journal:  J Math Biol       Date:  2012-07-25       Impact factor: 2.259

3.  Plasma interleukin-8 levels are persistently elevated for 1 month after minimally invasive colorectal resection for colorectal cancer.

Authors:  H M C Shantha Kumara; Elli Sutton; Geoffrey A Bellini; Xiaohong Yan; Vesna Cekic; Nipa Dilip Gandhi; Richard L Whelan
Journal:  Mol Clin Oncol       Date:  2017-12-18

4.  Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells.

Authors:  Kathrin Rupertus; Otto Kollmar; Claudia Scheuer; Bastian Junker; Michael D Menger; Martin K Schilling
Journal:  Clin Exp Metastasis       Date:  2007-01-27       Impact factor: 5.150

5.  Heterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapy.

Authors:  Kelly E Fathers; Courtney M Stone; Kanwal Minhas; Jason J A Marriott; Janice D Greenwood; Daniel J Dumont; Brenda L Coomber
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

6.  Comparative efficacy and adverse reactions of apatinib-chemotherapy combinations versus chemotherapy alone for treatment of advanced colorectal cancer: a meta-analysis of randomized controlled trials.

Authors:  Dengsheng Chen; Xinzhu Zhong; Lei Lin; Jiejie Xie; Yubao Lian; Luning Xu
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

7.  Plasma chitinase 3-like 1 is persistently elevated during first month after minimally invasive colorectal cancer resection.

Authors:  H M C Shantha Kumara; David Gaita; Hiromichi Miyagaki; Xiaohong Yan; Sonali Ac Hearth; Linda Njoh; Vesna Cekic; Richard L Whelan
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

Review 8.  Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.

Authors:  Louis de Mestier; Gilles Manceau; Cindy Neuzillet; Jean Baptiste Bachet; Jean Philippe Spano; Reza Kianmanesh; Jean Christophe Vaillant; Olivier Bouché; Laurent Hannoun; Mehdi Karoui
Journal:  World J Gastrointest Oncol       Date:  2014-06-15

9.  Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

Authors:  Sabine Venderbosch; Johannes H de Wilt; Steven Teerenstra; Olaf J Loosveld; Aart van Bochove; Harm A Sinnige; Geert-Jan M Creemers; Margot E Tesselaar; Linda Mol; Cornelis J A Punt; Miriam Koopman
Journal:  Ann Surg Oncol       Date:  2011-08-06       Impact factor: 5.344

Review 10.  Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

Authors:  Xiao-Feng Sun; Hong Zhang
Journal:  Mol Cancer       Date:  2006-10-06       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.